Purpose/Objectives: To describe the psychosocial trajectories of men treated surgically for prostate cancer after monitoring their prostate-specific antigen (PSA) levels until 24 months post-treatment.Design: Descriptive longitudinal study.Setting: Urology clinic at Duke University Health System.Sample: 12 men diagnosed and treated for prostate cancer.Methods: Men were interviewed in their homes at baseline and at 24 months and via telephone at 6, 12, and 18 months. Scores from the Profile of Mood States, Mishel Uncertainty in Illness Scale, Self-Control Schedule, and Cantril\u27s Ladder were entered into a database for analysis. Graphs of individual participants\u27 scores were plotted.Main Research Variables: PSA values, mood state, cogni...
Abstract Objective Prostate cancer (PCA) is the most common malignancy and a major cause of death in...
Objective: To explore ongoing symptoms, unmet needs, psychological wellbeing, self-efficacy and over...
Purpose: There are known associations between treatment of prostate cancer (PCa) involving Androgen ...
Objective: To address concerns over the psychological impact of being on a monitoring pathway follow...
BACKGROUND: To describe trajectories of health-related quality of life (QoL), life satisfaction, and...
OBJECTIVE: Little is known about the influence of psycho-social factors on health-related quality of...
Background Men treated for prostate cancer experience heightened psychological distress and have an ...
Objective: To examine the psychological and social adjustment of men with early or advanced stage pr...
Objective: To assess psychosocial distress in patients with early (localised) and advanced (metastat...
OBJECTIVE: Prostate cancer (PCA) is the most common malignancy and a major cause of death in men but...
Purpose: Many men with prostate cancer are asymptomatic, diagnosed following prostate specific antig...
BACKGROUND: Studies enumerating the dynamics of physical and emotional symptoms following prostate c...
Purpose: There are known associations between treatment of prostate cancer (PCa) involving Androgen ...
Objective: Studies indicate that social constraints (barriers to emotional expression) may be a risk...
Objective. To address concerns over the psychological impact of being on a monitoring pathway follow...
Abstract Objective Prostate cancer (PCA) is the most common malignancy and a major cause of death in...
Objective: To explore ongoing symptoms, unmet needs, psychological wellbeing, self-efficacy and over...
Purpose: There are known associations between treatment of prostate cancer (PCa) involving Androgen ...
Objective: To address concerns over the psychological impact of being on a monitoring pathway follow...
BACKGROUND: To describe trajectories of health-related quality of life (QoL), life satisfaction, and...
OBJECTIVE: Little is known about the influence of psycho-social factors on health-related quality of...
Background Men treated for prostate cancer experience heightened psychological distress and have an ...
Objective: To examine the psychological and social adjustment of men with early or advanced stage pr...
Objective: To assess psychosocial distress in patients with early (localised) and advanced (metastat...
OBJECTIVE: Prostate cancer (PCA) is the most common malignancy and a major cause of death in men but...
Purpose: Many men with prostate cancer are asymptomatic, diagnosed following prostate specific antig...
BACKGROUND: Studies enumerating the dynamics of physical and emotional symptoms following prostate c...
Purpose: There are known associations between treatment of prostate cancer (PCa) involving Androgen ...
Objective: Studies indicate that social constraints (barriers to emotional expression) may be a risk...
Objective. To address concerns over the psychological impact of being on a monitoring pathway follow...
Abstract Objective Prostate cancer (PCA) is the most common malignancy and a major cause of death in...
Objective: To explore ongoing symptoms, unmet needs, psychological wellbeing, self-efficacy and over...
Purpose: There are known associations between treatment of prostate cancer (PCa) involving Androgen ...